Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 13-20

  Cuartero Plaza, Alfons ^a   Martínez Miralles, Emili ^b   Rosell, Rafael ^c   Vadell Nadal, Caterina ^b   Farré, Magí ^a   Real, Francisco X ^a,d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d Departament d'Immunologia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; METOCLOPRAMIDE; PARACETAMOL; RECOMBINANT EPIDERMAL GROWTH FACTOR I 131; SERUM ALBUMIN TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; LUNG SCINTISCANNING; MALE; NAUSEA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EPIDERMAL GROWTH FACTOR; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MIDDLE AGED;

EID: 0030049664     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ginsberg, R. J., Kris, M. G., and Armstrong, J. G. Cancer of the lung. In: V. T. De Vita, S. Hellman, and S. A. Rosenberg (eds.), Cancer. Principles and Practice of Oncology, pp. 673-758. Philadelphia: J. B. Lippincott Company, 1993.
2. Mountain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl. 4): 225S-233S, 1986.
3. Rosell, R., Gómez-Codina, J., Camps, C., Maestre, J., Padille, J., Cantó, A., Mate, J. L., Li, S., Toig, J., Olazábal, A., Canela, M., Ariza, A. Skácet, Z., Morera-Prat, J., and Abad, A. A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N. Engl. J. Med., 330: 153-158, 1994.
4. Slebos, R. J., Kibbelaar, R. E., Daksio, O., Kooistra, A., Stam, J., Meijer, C. J., Wagenaar, S. S., Vandershueren, R. G., van Zandwijk, N., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
5. Hendler, F. J., and Ozanne, B. W. Human squamous cell lung cancers express increased epidermal growth factor receptors. J. Clin. Invest., 74: 647-651, 1984.
6. Ozanne, B., Shum, A., Richards, C. S., Cassells, D., Grossman, D., Trent, J., Gusterson, B., and Hendler, F. Evidence for an increase of EGF receptors in epidermoid malignancies Cancer Cells (Cold Spring Harbor), 3: 41-49, 1985.
7. Lin, C. R., Chen, W. S., Kruiger, W., Stolarsky, L. S., Weber, W., Evans, R. M., Verma, I. M., Gill, G. N., and Rosenfeld, M G. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science (Wash. DC), 224: 843-848, 1984.
8. Bigner, S. H , Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, S. H , and Bigner, D D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res., 50: 8017-8022, 1990.
9. Derynck, R., Goeddel, D V , Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
10. Cohen, S , Ushiro, H. Stoscheck, C., and Chinkers, M. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J. Biol. Chem., 257: 1523-1531, 1982.
11. Todaro, G. J , Rose, T. M., Spooner, C. E., Shoyab, M., and Plowman, G. D. Cellular and viral ligands that interact with the EGF receptor. Semin. Cancer Biol., 1: 257-263, 1990.
12. Reiss, M., Stash, E. B., Vellucci, V. F., and Zhou, Z. I. Activation of the autocrine transforming growth factor α pathway in human squamous carcinoma cells. Cancer Res., 51: 6254-6262, 1992.
13. Hunter, W. M., and Greenwood, F. C Preparation of iodine-131 labeled growth hormone of high specific radioactivity. Nature (Lond.), 194: 495-496, 1962.
14. Divgi, C. R., Welt, S., Kris, M., Real, F. X., Yeh, S. D., Gralla, R., Merchant, B., Schweighart, S., Unger, M., Larson, S. M., and Mendelsohn, J. Phase I and imaging trial of indium-111 labeled anti-EGF receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst., 83: 97-104, 1991.
15. 111In (Abstract). Proc. Am. Soc. Clin. Oncol., 12: 142A, 1993.
16. Pérez-Soler, R. Donato, N. J., Shin, D. M., Rosenblum, M. G., Zhang, H. Z., Tornos, C., Brewer, H., Chan, J. C., Lee, J. S., Hong, W. K , and Murray, J. L. Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852. J. Clin. Oncol., 12: 730-739, 1994.
17. 123I-labelled epidermal growth factor. Lancet. 337: 395-396, 1991.
18. Fraker, P. J., and Speck, J. C. Protein and cell membrane iodinations with a sparingly soluble chloramide. 1,3,4,6-tetrachloro-3a,6-diphenylglycoluril. Biochem. Biophys. Res. Commun., 80, 849-857, 1978.
19. Welt, S., Divgi, C. R., Real, F. X., Yeh, S. D., Garin-Chesa, P., Findstad, C. L., Sakamoto, J., Cohen, A., Sigurdson, E. R., Kemeny, N., Carswell, E. A , Oettgen, H. F., and Old, L. J. Quantitative analysis of antibody localization in human metastatic colon cancer: a Phase I study of monoclonal antibody A33. J. Clin. Oncol., 8: 1894-1906, 1990.
20. Shumaker, R. C. PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev., 17: 331-348, 1986.
21. Kawamoto, T., Sato, J D., Le, A. D., Polikoff, J., Sato, G. H., and Mendelsohn, J. Growth stimulation of A431 cells by EGF: identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA, 80: 1337-1341, 1983.
22. Baselga, J., Norton, L , Masui, H., Pandiella, A., Coplan, K., Miller, W. H., Jr., and Mendelsohn, J Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst. 85: 1327-1333, 1993.
23. Goldenberg, D. M. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy. Semin. Nucl. Med., 19: 332-339, 1989.
24. Larson, S. M. Radioimmunology. Imaging and therapy. Cancer (Phila.), 67: 1253-1260, 1991.
25. Goldenberg, D. M., and Larson, S. M. Radioimmunodetection in cancer identification. J. Nucl. Med., 33: 803-814, 1992.
26. 2. J. Nucl. Med., 24: 316-325, 1983.
27. Larson, S. M., Carrasquillo, J. A., Krohn, K. A., Brown, J. P., McGuffin, R. W., Ferens, J. M., Graham, M. M., Hill, L. D., Beaumier, P. L., and Hellstrom, K. E. Localization of p97 specific Fab fragments in human melanoma as a basis for radiotherapy. J. Clin. Invest. 72: 2101-2114, 1983.
28. Buchegger, F., Halpern, S. E., Sutherland, R. M., Schreyer, M., and Mach, J. P. In vitro and in vivo tumor models for studies of distribution of radiolabelled monoclonal antibodies and fragments. Nuklearmedizin, 25: 207-209, 1986.
29. Goodlad, R., Wilson, G., Lenton, W., Gregory, H., MacCullagh, K., and Wrigth, N. Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut, 28: 573-582, 1987.
30. Foster, H. M., and Whitehead, R. H. Intravenous but not intracolonic epidermal growth factor maintains colonocyte proliferation in defunctioned rat colorectum. Gastroenterology, 99: 1710-1714, 1990.
31. Bender, H., Emrich, J. G., Frey, M., Biersack, H. J., and Brady, L. W Differences in the pharmacokinetics of EGF and a monoclonal antibody to the EGF-receptor in human glioma cell lines in vitro (Abstract). Eur. J. Nucl. Med., 20: 970A, 1993.
32. Krenning, E. P., Bakker, W. H., Breeman, W. A. P., Koper, J. W., Kooij, P. P., Ausema, L., Lameris, J. S., Reubi, J. C., and Lamberts, S. W. Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet, 1: 242-244, 1989.
33. Virgolini, I., Raderer, M., Kurtaran, A , Angelberger, P., Banyai, S , Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., Scheithauser, W., and Valent, P. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med., 331: 1116-1121, 1994.